Other Assets, Noncurrent in USD of Oruka Therapeutics, Inc. from Q4 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Oruka Therapeutics, Inc. quarterly Other Assets, Noncurrent history and change rate from Q4 2010 to Q3 2025.
  • Oruka Therapeutics, Inc. Other Assets, Noncurrent for the quarter ending 30 Sep 2025 was $103K, a 140% increase year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

Oruka Therapeutics, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $103K +$60K +140% 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $103K +$91K +758% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $103K +$91K +758% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $43K +$31K +258% 31 Dec 2024 10-Q 12 Nov 2025
Q3 2024 $43K +$31K +258% 30 Sep 2024 10-Q 13 Nov 2024
Q2 2024 $12K -$6K -33.3% 30 Jun 2024 10-Q 01 Aug 2024
Q1 2024 $12K -$6K -33.3% 31 Mar 2024 10-Q 25 Apr 2024
Q4 2023 $12K -$6K -33.3% 31 Dec 2023 10-Q 01 Aug 2024
Q3 2023 $12K -$6K -33.3% 30 Sep 2023 10-Q 18 Oct 2023
Q2 2023 $18K $0 0% 30 Jun 2023 10-Q 21 Jul 2023
Q1 2023 $18K $0 0% 31 Mar 2023 10-Q 24 Apr 2023
Q4 2022 $18K $0 0% 31 Dec 2022 10-K 01 Feb 2024
Q3 2022 $18K $0 0% 30 Sep 2022 10-Q 28 Oct 2022
Q2 2022 $18K $0 0% 30 Jun 2022 10-Q 02 Aug 2022
Q1 2022 $18K +$6K +50% 31 Mar 2022 10-Q 02 May 2022
Q4 2021 $18K +$6K +50% 31 Dec 2021 10-K 24 Feb 2023
Q3 2021 $18K -$18K -50% 30 Sep 2021 10-Q 02 Nov 2021
Q2 2021 $18K -$6K -25% 30 Jun 2021 10-Q 04 Aug 2021
Q1 2021 $12K -$12K -50% 31 Mar 2021 10-Q 11 May 2021
Q4 2020 $12K -$12K -50% 31 Dec 2020 10-K 14 Mar 2022
Q3 2020 $36K +$12K +50% 30 Sep 2020 10-Q 02 Nov 2020
Q2 2020 $24K $0 0% 30 Jun 2020 10-Q 05 Aug 2020
Q1 2020 $24K $0 0% 31 Mar 2020 10-Q 06 May 2020
Q4 2019 $24K $0 0% 31 Dec 2019 10-K 18 Mar 2021
Q3 2019 $24K $0 0% 30 Sep 2019 10-Q 06 Nov 2019
Q2 2019 $24K $0 0% 30 Jun 2019 10-Q 01 Aug 2019
Q1 2019 $24K $0 0% 31 Mar 2019 10-Q 08 May 2019
Q4 2018 $24K $0 0% 31 Dec 2018 10-K 18 Feb 2020
Q3 2018 $24K -$473K -95.2% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $24K -$563K -95.9% 30 Jun 2018 10-Q 09 Aug 2018
Q1 2018 $24K -$652K -96.5% 31 Mar 2018 10-Q 08 May 2018
Q4 2017 $24K -$742K -96.9% 31 Dec 2017 10-K 27 Feb 2019
Q3 2017 $497K -$358K -41.9% 30 Sep 2017 10-Q 09 Nov 2017
Q2 2017 $587K -$229K -28.1% 30 Jun 2017 10-Q 03 Aug 2017
Q1 2017 $676K +$96K +16.6% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $766K +$136K +21.6% 31 Dec 2016 10-K 22 Mar 2018
Q3 2016 $855K +$176K +25.9% 30 Sep 2016 10-Q 14 Nov 2016
Q2 2016 $816K +$62K +8.22% 30 Jun 2016 10-Q 09 Aug 2016
Q1 2016 $580K +$27K +4.88% 31 Mar 2016 10-Q 11 May 2016
Q4 2015 $630K +$22K +3.62% 31 Dec 2015 10-K 21 Mar 2017
Q3 2015 $679K +$131K +23.9% 30 Sep 2015 10-Q 12 Nov 2015
Q2 2015 $754K -$77K -9.27% 30 Jun 2015 10-Q 11 Aug 2015
Q1 2015 $553K -$275K -33.2% 31 Mar 2015 10-Q 12 May 2015
Q4 2014 $608K +$478K +368% 31 Dec 2014 10-K 17 Mar 2016
Q3 2014 $548K +$448K +448% 30 Sep 2014 10-Q 12 Nov 2014
Q2 2014 $831K +$727K +699% 30 Jun 2014 10-Q 13 Aug 2014
Q1 2014 $828K +$704K +568% 31 Mar 2014 10-Q 13 May 2014
Q4 2013 $130K -$14K -9.72% 31 Dec 2013 10-K 19 Mar 2015
Q3 2013 $100K -$64K -39% 30 Sep 2013 10-Q 13 Nov 2013
Q2 2013 $104K -$79K -43.2% 30 Jun 2013 10-Q 13 Aug 2013
Q1 2013 $124K -$80K -39.2% 31 Mar 2013 10-Q 13 May 2013
Q4 2012 $144K -$80K -35.7% 31 Dec 2012 10-K 20 Mar 2014
Q3 2012 $164K -$80K -32.8% 30 Sep 2012 10-Q 13 Nov 2012
Q2 2012 $183K -$81K -30.7% 30 Jun 2012 10-Q 13 Aug 2012
Q1 2012 $204K 31 Mar 2012 10-Q 14 May 2012
Q4 2011 $224K -$80K -26.3% 31 Dec 2011 10-K 21 Mar 2013
Q3 2011 $244K 30 Sep 2011 10-Q 14 Nov 2011
Q2 2011 $264K 30 Jun 2011 10-Q 15 Aug 2011
Q4 2010 $304K 31 Dec 2010 10-K 27 Mar 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.